| Serial Number | 99603537 |
| Word Mark | WITHZETA |
| Filing Date | Tuesday, January 20, 2026 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Tuesday, June 23, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Providing temporary use of a non-downloadable artificial intelligence software platform featuring software for {specify the function of the software} in the fields of scientific and biomedical research; providing an online software-as-a-service (SaaS) platform featuring artificial intelligence and machine-learning software for analyzing biological, genomic, proteomic, clinical, and pharmacological data; scientific research services using artificial intelligence in the field of oncology and rare diseases; providing temporary use of a non-downloadable artificial intelligence software platform featuring software for computational models and simulations for identifying, evaluating, and prioritizing therapeutic targets, drug candidates, and combination therapies in the field of oncology; Providing on-line non downloadable software using artificial intelligence (AI) for hypothesis generation, in silico experimentation, and data-driven scientific research in the fields of {specify}; providing an online software-as-a-service (SaaS) platform featuring softwarefor designing, modeling, and optimizing clinical trial concepts and research protocols for investigational medical therapies; providing an online software-as-a-service (SaaS) platform featuring software for predictive analytics, biomarker discovery, drug response modeling, and validation of scientific hypotheses in the fields of oncology; providing scientific data analysis, visualization, and interpretation services using artificial intelligence in the field of oncology;providing an online software-as-a-service (SaaS) platform featuring software for accelerating biomedical research and development of therapeutic drugs through computational model simulations; Providing medical and scientific research information in the field of oncology and rare diseases; providing information and analysis relating to biomedical research and drug discovery, not for the purpose of diagnosis or treatment. |
| Pseudo Mark | WITH ZETA |
| Goods and Services | Downloadable computer software for providing computational models and simulations for identifying, evaluating, and prioritizing therapeutic targets, drug candidates, and combination therapies; downloadable artificial intelligence software platform featuring software for hypothesis generation, in silico experimentation, and data-driven scientific discovery in the field of oncology; downloadable computer software for designing, modeling, and optimizing clinical trial concepts and research protocols for research of medical therapies; downloadable computer software for predictive analytics, biomarker discovery, drug response modeling, and validation of scientific hypotheses in the field of oncology |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 18, 2026 |
| Primary Code | 009 |
| First Use Anywhere Date | Tuesday, January 20, 2026 |
| First Use In Commerce Date | Tuesday, January 20, 2026 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 20, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, January 20, 2026 |
| First Use In Commerce Date | Tuesday, January 20, 2026 |
| Party Name | Lantern Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75201 US |
| Event Date | Event Description |
| Tuesday, January 20, 2026 | NEW APPLICATION ENTERED |
| Tuesday, January 20, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 7, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, May 17, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, May 26, 2026 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 26, 2026 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 26, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 18, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 18, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 18, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 23, 2026 | SUSPENSION LETTER WRITTEN |
| Tuesday, June 23, 2026 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, June 23, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |